Patent details

EP2308898 Title: Internalizing anti-CD74 antibodies and methods of use

Basic Information

Publication number:
EP2308898
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP100093962
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Internalizing anti-CD74 antibodies and methods of use
French Title of Invention:
Internalisation d'anticorps anti-CD74 et procédés d'utilisation
German Title of Invention:
Anti CD74 monoklonale Antikörper
SPC Number:

Dates

Filing date:
03/03/2003
Grant date:
08/06/2016
EP Publication Date:
08/06/2016
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
13/04/2011
EP B1 Publication Date:
08/06/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
03/03/2017
Expiration date:
03/03/2023
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
03/03/2003
 
 

Name:
Immunomedics Inc.
Address:
300 American Road, Morris Plains, NJ 07950, United States (US)

Inventor

1

Name:
Leung Shui-on
Address:
United States (US)

2

Name:
Hansen Hans
Address:
United States (US)

3

Name:
Qu Zhengxing
Address:
United States (US)

4

Name:
Goldenberg David M.
Address:
United States (US)

Priority

Priority Number:
360259 P
Priority Date:
01/03/2002
Priority Country:
United States (US)

Classification

Main IPC Class:
C07K 16/28;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages